Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$217K Sell
1,835
-167
-8% -$19.3K 0.02% 427
2026
Q1
$239K Sell
2,002
-123
-6% -$16.1K 0.02% 376
2025
Q4
$289K Sell
2,125
-68
-3% -$9.78K 0.03% 282
2025
Q3
$323K Buy
2,193
+173
+9% +$24K 0.03% 266
2025
Q2
$261K Sell
2,020
-468
-19% -$56.7K 0.03% 282
2025
Q1
$297K Sell
2,488
-293
-11% -$36.3K 0.04% 238
2024
Q4
$323K Sell
2,781
-197
-7% -$24.9K 0.04% 238
2024
Q3
$402K Sell
2,978
-19
-0.6% -$2.54K 0.05% 207
2024
Q2
$406K Sell
2,997
-1,393
-32% -$190K 0.06% 195
2024
Q1
$567K Buy
4,390
+269
+7% +$32.5K 0.1% 152
2023
Q4
$471K Buy
+4,121
New +$411K 0.09% 163

Other funds holding XYL

LVW Advisors's XYL Position: Q2 2026 in Review

LVW Advisors reduced its Xylem (XYL) stake by 8.3% in Q2 2026, selling an estimated $19.3K and leaving 1,835 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #427.

LVW Advisors first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $567K in Q1 2024. 399 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • LVW Advisors held 1,835 shares of Xylem worth $217K as of Q2 2026.
  • LVW Advisors sold 167 Xylem shares in Q2 2026, an estimated $19.3K.
  • Xylem made up 0.02% of LVW Advisors's portfolio in Q2 2026, its #427 holding.
  • LVW Advisors first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
  • LVW Advisors's Xylem position peaked at $567K in Q1 2024.
  • 399 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.